Evidence for pleiotropic signaling at the mouse beta3-adrenoceptor revealed by SR59230A [3-(2-Ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate]
- PMID: 15574684
- DOI: 10.1124/jpet.104.076901
Evidence for pleiotropic signaling at the mouse beta3-adrenoceptor revealed by SR59230A [3-(2-Ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate]
Abstract
This study examines the action of the beta(3)-adrenoceptor antagonist SR59230A [3-(2-ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanoloxalate] at cloned mouse beta(3)-adrenoceptors expressed in Chinese hamster ovary cells (CHO-K1-beta(3)) or endogenously expressed in 3T3-F442A adipocytes or ileum. SR59230A displayed partial agonist properties compared with the beta(3)-adrenoceptor agonist CL316243 [(R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino]-propyl]1,3-benzodioxole-2,2-dicarboxylate] in CHO-K1-beta(3) with the intrinsic activity increasing with the level of receptor expression. Functional affinity values for SR59230A at each level of receptor expression were in agreement with pK(I) values determined by binding. In cytosensor microphysiometer studies, SR59230A was a full agonist for increases in extracellular acidification rates (ECARs) at all levels of receptor expression, and antagonist actions were measurable only in medium- or low-expressing cells. In 3T3-F442A adipocytes, SR59230A antagonized CL316243-mediated increases of cAMP and had no agonist actions. However, in the cytosensor micro-physiometer, SR59230A (acting via beta(3)-adrenoceptors) was an agonist with an intrinsic activity greater than CL316243. In mouse ileum, SR59230A relaxed smooth muscle, although concentration-response curves were biphasic. Relaxant effects were produced by concentrations that did not affect cAMP levels. Differences in tissue responses to SR59230A were not caused by major differences in expression of Galphas. ECAR responses were not affected by pretreatment of cells with pertussis toxin, indicating that signaling did not involve Gi. Therefore, SR59230A displays agonist and antagonist actions at the mouse beta(3)-adrenoceptor. Because SR59230A only antagonized accumulation of cAMP in 3T3-F442A adipocytes yet in the same cells was an agonist for ECAR, cAMP-independent signaling pathways must mediate part of the agonist actions in the microphysiometer.
Similar articles
-
Tools to study beta3-adrenoceptors.Naunyn Schmiedebergs Arch Pharmacol. 2007 Feb;374(5-6):385-98. doi: 10.1007/s00210-006-0127-5. Epub 2007 Jan 9. Naunyn Schmiedebergs Arch Pharmacol. 2007. PMID: 17211601 Review.
-
Ligand-directed signaling at the beta3-adrenoceptor produced by 3-(2-Ethylphenoxy)-1-[(1,S)-1,2,3,4-tetrahydronapth-1-ylamino]-2S-2-propanol oxalate (SR59230A) relative to receptor agonists.Mol Pharmacol. 2007 Nov;72(5):1359-68. doi: 10.1124/mol.107.035337. Epub 2007 Aug 23. Mol Pharmacol. 2007. PMID: 17717109
-
Functional domains of the mouse beta3-adrenoceptor associated with differential G protein coupling.J Pharmacol Exp Ther. 2005 Dec;315(3):1354-61. doi: 10.1124/jpet.105.091736. Epub 2005 Sep 6. J Pharmacol Exp Ther. 2005. PMID: 16144970
-
beta(3)-adrenoceptor regulation and relaxation responses in mouse ileum.Br J Pharmacol. 2000 Mar;129(6):1251-9. doi: 10.1038/sj.bjp.0703160. Br J Pharmacol. 2000. PMID: 10725275 Free PMC article.
-
The odd sibling: features of β3-adrenoceptor pharmacology.Mol Pharmacol. 2014 Nov;86(5):479-84. doi: 10.1124/mol.114.092817. Epub 2014 Jun 2. Mol Pharmacol. 2014. PMID: 24890609 Review.
Cited by
-
Agonist effects of zinterol at the mouse and human beta(3)-adrenoceptor.Naunyn Schmiedebergs Arch Pharmacol. 2006 May;373(2):158-68. doi: 10.1007/s00210-006-0056-3. Epub 2006 Apr 7. Naunyn Schmiedebergs Arch Pharmacol. 2006. PMID: 16601951
-
Tools to study beta3-adrenoceptors.Naunyn Schmiedebergs Arch Pharmacol. 2007 Feb;374(5-6):385-98. doi: 10.1007/s00210-006-0127-5. Epub 2007 Jan 9. Naunyn Schmiedebergs Arch Pharmacol. 2007. PMID: 17211601 Review.
-
The discovery of drugs for obesity, the metabolic effects of leptin and variable receptor pharmacology: perspectives from beta3-adrenoceptor agonists.Naunyn Schmiedebergs Arch Pharmacol. 2008 Aug;378(2):225-40. doi: 10.1007/s00210-008-0271-1. Epub 2008 Jul 9. Naunyn Schmiedebergs Arch Pharmacol. 2008. PMID: 18612674 Review.
-
Interaction with caveolin-1 modulates G protein coupling of mouse β3-adrenoceptor.J Biol Chem. 2012 Jun 8;287(24):20674-88. doi: 10.1074/jbc.M111.280651. Epub 2012 Apr 25. J Biol Chem. 2012. PMID: 22535965 Free PMC article.
-
Mixed beta3-adrenoceptor agonist and alpha1-adrenoceptor antagonist properties of nebivolol in rat thoracic aorta.Br J Pharmacol. 2006 Apr;147(7):699-706. doi: 10.1038/sj.bjp.0706648. Br J Pharmacol. 2006. PMID: 16474420 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources